Robert Tansley

Robert joined Cambridge Innovation Capital as the Investment Director for Life Sciences in January 2014 after 20 years’ experience in the pharma/biotech industry working both at large pharma (Sanofi, Roche), the MHRA and in VC backed companies (Arakis, KalVista) including founding the malaria therapeutics company Treague and as founding CEO of Avilex Pharma. Robert qualified in medicine at University College London; he is a member of the Royal College of Obstetricians and Gynecologists and the Faculty of Pharmaceutical Medicine. He has an MBA from London Business School and an MPhil in Biostatistics from the University of Cambridge.